Blood pressure in acute stroke: In search of evidence

Journal of Hypertension

Volumn 23, Issue 2, 2005, Pages 277-278

  Chalmers, John ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT;

BLOOD PRESSURE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; DRUG INDICATION; EDITORIAL; EUROPE; EVIDENCE BASED MEDICINE; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; SCORING SYSTEM; STROKE; WORLD HEALTH ORGANIZATION;

EID: 14044252216     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200502000-00008     Document Type: Editorial

References (17)

1. Blood Pressure in Acute Stroke Collaboration (BASC). Interventions for deliberately altering blood pressure in acute stroke (Cochrane Review). The Cochrane Library, issue 1. Chichester, UK: John Wiley & Sons; 2004.
2. Hacke W, Kaste M, Bogousslavsky J, Brainin M, Chamorro A, Lees K, et al., for the European Stroke Initiative Executive Committee. European stroke initiative recommendations for stroke management-update 2003. Cerebrovasc Dis 2003; 16:311-337.
3. Adams HP Jr, Adams RJ, Brott T, del Zoppo GJ, Furlan A, Goldstein LB, et al. Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003; 34:1056-1083.
4. Bath P, Chalmers J, Powers W, Beilin L, Davis S, Lenfant C, et al., for the International Society of Hypertension Writing Group. International society of hypertension (ISH): Statement on the management of blood pressure in acute stroke. J Hypertens 2003; 21:665-672.
5. Joint Committee for Stroke Guidelines. Guidelines for Management of Stroke [in Japanese] 2004. Available at: http://www.jsts.grjp/jss0tml.
6. The Intercollegiate Working Party for Stroke. National clinical guidelines for stroke. London: Royal College of Physicians, 2nd edn; 2004. Available at: http://www.rcplondon.ac.uk.
7. National Stroke Foundation of Australia. National clinical guidelines for acute stroke management; 2003. Available at: http://www.strokefoundation.com. au.
8. Stroke Foundation New Zealand. Life after stroke: New Zealand Guideline for management of stroke; 2003. Available at: http://www.nzgg.orgnz.
9. Lindley RI, Amayo EO, Marshall J, Sandercock PA, Dennis M, Warlow CP. Acute stroke treatment in UK hospitals: the Stroke Association survey of consultant opinion. JR Coll Physicians Lond 1995; 29:479-484.
10. Goldstein LB. Blood pressure management in patients with acute ischemic stroke. Hypertension 2004; 43:137-141.
11. The COSSACS Trial Goup. COSSACS (Continue or Stop post-Stroke Antihypertensive Collaborative Study): Rationale and Design. J Hypertens 2005; 23:455-458.
12. Rudd AG, Lowe D, Hoffman A, Irwin P, Pearson M. Secondary prevention for stroke in the United Kingdom: results of the National Sentinel Audit of Stroke. Ageing 2004; 33:280-286.
13. Potter JF, Robinson TG. Controlling Hypertension and Hypotension Immediately Post-Stroke Trial. Stroke 2004; 35:165.
14. Schrader J, Luders S, Kulschewski A, Berger J, Zidek W, Treib J, et al. The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors. Stroke 2003; 34:1599-1703.
15. Bath PM, Pathansali R, Iddenden R, Bath FJ. The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and platelet function in acute stroke. Cerebrovasc Dis 2001; 11:265-272.
16. Eames PJ, Robinson TG, Panerai RB, Potter JF. The systemic haemodynamic and cerebral autoregulatory effects of bendrofluazide in the subacute post-stroke period. J Hypertens 2005; 23:000-000.
17. Intravenous Magnesium for Efficacy in Acute Stroke (IMAGES) Study Investigators. Magnesium for acute stroke. Lancet 2004; 363:439-445.